0001104659-17-002823.txt : 20170118
0001104659-17-002823.hdr.sgml : 20170118
20170118170145
ACCESSION NUMBER: 0001104659-17-002823
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170113
FILED AS OF DATE: 20170118
DATE AS OF CHANGE: 20170118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adaptimmune Therapeutics PLC
CENTRAL INDEX KEY: 0001621227
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 101 PARK DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON, OXFORDSHIRE
STATE: X0
ZIP: OX14 4RY
BUSINESS PHONE: 44 1235 430000
MAIL ADDRESS:
STREET 1: 101 PARK DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON, OXFORDSHIRE
STATE: X0
ZIP: OX14 4RY
FORMER COMPANY:
FORMER CONFORMED NAME: Adaptimmune Ltd
DATE OF NAME CHANGE: 20141001
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amado Rafael
CENTRAL INDEX KEY: 0001662119
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37368
FILM NUMBER: 17534005
MAIL ADDRESS:
STREET 1: 5 ASHWOOD LANE
CITY: MALVERN
STATE: PA
ZIP: 19435
4
1
a4.xml
4
X0306
4
2017-01-13
0
0001621227
Adaptimmune Therapeutics PLC
ADAP
0001662119
Amado Rafael
5 ASHWOOD LANE
MALVERN
PA
19436
0
1
0
0
Chief Medical Officer
Option to purchase Ordinary Shares
0.72
2017-01-13
4
A
0
2072976
0
A
2027-01-13
Ordinary Shares
2072976
2072976
D
The exercise price was converted from GBP0.59 based on the closing midpoint exchange rate for the U.S. dollar on the day prior to the date of grant listed in the Financial Times. The actual exercise price will be the pounds sterling amount.
Exercisable as to 518,244 Ordinary Shares on January 13, 2018 and will be exercisable as to the remainder in monthly installments of 43,187 Ordinary Shares on the thirteenth of each month from February 13, 2018 through January 13, 2021.
/s/ Rafael Amado
2017-01-18